Answers are grounded in this paper and cite their sources.
BACKGROUND: Stereotactic radiosurgery (SRS) is an established treatment for vestibular schwannoma (VS), primarily for tumors smaller than 3 cm in diameter. Its role in larger tumors remains controversial and is generally limited to carefully selected patients. This study evaluated long-term outcomes of primary single-session SRS for VS, stratified by tumor size. METHODS: We retrospectively analyzed 160 patients with unilateral sporadic VS treated with SRS between July 2009 and September 2020. SRS was primarily indicated for tumors <3 cm in maximum diameter, while larger tumors were selectively treated in patients without significant brainstem compression or severe neurological deficits. Patients were stratified by Koos grade: Group A (I), Group B (II-III), and Group C (IV). Median follow-up was 96 months. Primary outcomes included progression-free survival (PFS), hearing preservation, and treatment-related complications. New-onset trigeminal neuralgia occurred in 0%, 0.9%, and 6.1% of patients in Groups A, B, and C, respectively. Post-SRS hydrocephalus requiring ventriculoperitoneal shunting was observed in 0%, 5.6%, and 27.3%, respectively. CONCLUSION: Within appropriately selected patients, SRS provides excellent tumor control across tumor sizes. However, the risks of trigeminal neuralgia and hydrocephalus requiring shunting increased with tumor size, underscoring the need for individualized treatment strategies.
No takes yet. Share an insight, caveat, or question.
An et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: